Home / Salmeterol and Fluticasone / United States
US ATC R03AK06 · updated 2 Nov 2026
Salmeterol and Fluticasone shortage in United States
Is there a Salmeterol and Fluticasone shortage in United States?
Yes. As of 2 Nov 2026, 3 Salmeterol and Fluticasone products are reported short in United States, the first since 27 Jul 2026. No return date has been given. Main reason: not stated.
Also short in Italy, Ireland, Austria, Czechia, Norway. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Advair HFA, Aerosol, Metered, 115 ug; 21 ug (NDC 0173-0716-22) anticipated discontinuation | GlaxoSmithKline | 27 Jul 2026 | not given | Not stated |
| US | Advair HFA, Aerosol, Metered, 230 ug; 21 ug (NDC 0173-0717-22) anticipated discontinuation | GlaxoSmithKline | 27 Jul 2026 | not given | Not stated |
| US | Advair HFA, Aerosol, Metered, 45 ug; 21 ug (NDC 0173-0715-22) anticipated discontinuation | GlaxoSmithKline | 27 Jul 2026 | not given | Not stated |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).